Cue Biopharma, Inc.
€22.55
EUR
Last updated on --.
24h volume67.85K
24h highest25.3487 EUR
24h lowest21.9861 EUR
24h Price movement-8.60%
CUE recent prices
24 Hours
-8.60%-€2.122
30 days
-23.97%-€7.221
60 days
+400.28%+€18.32
90 days
+195.36%+€15.14
Key data
Previous close24.6762 EUR
Market cap76.39M EUR
Volume67.85K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-4.1644 EUR
Net income (FY)-16.83M EUR
Revenue (FY)28.22M EUR
Last report dateMay 14, 2026
About Cue Biopharma, Inc.
HeadquartersBOSTON
Employees (FY)29.00
Revenue per employee (FY)973.13K EUR
Net income per employee (FY)-580.44K EUR
Listed onNasdaq
CUE conversion tables
 |  |
|---|---|
| 0.5 CUE | 11.27 EUR |
| 1 CUE | 22.55 EUR |
| 5 CUE | 112.77 EUR |
| 10 CUE | 225.55 EUR |
| |
|---|---|
| 0.5 EUR | 0.022168 CUE |
| 1 EUR | 0.044336 CUE |
| 5 EUR | 0.22168 CUE |
| 10 EUR | 0.44336 CUE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CUE is trading at €22.55, -8.60% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CUE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CUE is currently trading at €22.55, -8.60% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CUE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CUE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CUE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CUE's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Cue Biopharma, Inc.'s market cap is currently 76.39M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume67.85K
24h highest25.3487 EUR
24h lowest21.9861 EUR
24h Price movement-8.60%
Start trade with CUE Perpetual
Sign up to trade